Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327 ...
Novel trispecific T cell engager, ZW209, demonstrates potent preclinical efficacy against DLL3-expressing tumors and an encouraging safety profile New antibody-drug conjugate (ADC) candidate, ZW327, ...
Indiana basketball's Mike Woodson coached his last game at Simon Skjodt Assembly Hall on Saturday. In a postgame interview with CBS after IU's 66-60 win over Ohio State, Woodson said "he couldn't ...
Indiana basketball's Mike Woodson coached his last game at Simon Skjodt Assembly Hall on Saturday. In a postgame interview with CBS after IU's 66-60 win over Ohio State, Woodson said "he couldn't be ...
HOUSE, PA — Third Arc Bio Inc. has administered the first dose of ARC101 to a patient in its inaugural first-in-human ...
MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy
Macbecin II was identified as a compound that upregulates MHC-I expression, enhancing immune-mediated cancer cell killing. In ...
Building upon ARC101 as a foundation, Third Arc Bio continues to invest in its Synergy Platform to develop a pipeline of novel CD3 and CD28 targeting multispecifics to create transformational drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback